International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2025   Volume 15   Issue 3

Phenotypic Screening Meets Machine Learning in Small-Molecule Discovery Through Cellular Signatures, Representation Learning, Mechanism Inference, and Compound Prioritization
Download PDF


, ,
  1. Department of Phenotypic Screening and Machine Learning, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  2. Department of Cellular Signatures and Mechanism Inference, Faculty of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Citation
Vancouver
Lahtinen M, Salo E, Virtanen J. Phenotypic Screening Meets Machine Learning in Small-Molecule Discovery Through Cellular Signatures, Representation Learning, Mechanism Inference, and Compound Prioritization. Int J Pharm Phytopharmacol Res. 2025;15(3):98-107. https://doi.org/10.51847/WhSV4kOqyu
APA
Lahtinen, M., Salo, E., & Virtanen, J. (2025). Phenotypic Screening Meets Machine Learning in Small-Molecule Discovery Through Cellular Signatures, Representation Learning, Mechanism Inference, and Compound Prioritization. International Journal of Pharmaceutical And Phytopharmacological Research, 15(3), 98-107. https://doi.org/10.51847/WhSV4kOqyu
Download citation:   EndNote   RIS
Article Link:
Downloads: 22
Views: 89
Abstract

Phenotypic screening measures compound‑induced biological change without requiring a predefined molecular target, yet modern assays increasingly generate images, transcriptional states, and other high‑dimensional readouts whose interpretation depends on computational representation. This integrative review synthesizes peer‑reviewed evidence published from 2017 through 2025 across image‑based profiling, perturbational transcriptomics, representation learning, mechanism inference, chemical–phenotypic modeling, compound prioritization, and experimental confounding, interpreting studies according to task definition, validation design, mechanistic evidence, and transferability rather than pooling across non‑equivalent benchmarks. The literature supports a progression from measured cellular responses to reusable signatures and learned representations that can support perturbation retrieval, activity prediction, response modeling, mechanism‑oriented hypothesis generation, and prioritization of compounds for testing, with morphological, transcriptional, and chemical representations providing overlapping but non‑equivalent information. This review proposes an integrated phenotype‑to‑decision framework in which mechanism inference and compound prioritization branch from learned biological‑response spaces while remaining conditioned by cell context, technical structure, applicability domain, and experimental validation. Strong internal prediction does not itself establish target identity, causal mechanism, external generalization, or prospective discovery value. Phenotypic machine learning is most defensible as an evidence‑organizing and hypothesis‑prioritizing strategy, and its discovery value depends on separating representational usefulness, mechanistic attribution, and experimentally validated decision use while treating discordance, confounding, and domain shift as scientific information rather than preprocessing nuisances.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 4
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.